Jiang, Y., Chen, M., Nie, H., & Yuan, Y. (2019). PD-1 and PD-L1 in cancer immunotherapy: Clinical implications and future considerations. Human vaccines & immunotherapeutics, 15(5), 1111-1122. https://doi.org/10.1080/21645515.2019.1571892
Chicago Style (17th ed.) CitationJiang, Yongshuai, Ming Chen, Hong Nie, and Yuanyang Yuan. "PD-1 and PD-L1 in Cancer Immunotherapy: Clinical Implications and Future Considerations." Human Vaccines & Immunotherapeutics 15, no. 5 (2019): 1111-1122. https://doi.org/10.1080/21645515.2019.1571892.
MLA (9th ed.) CitationJiang, Yongshuai, et al. "PD-1 and PD-L1 in Cancer Immunotherapy: Clinical Implications and Future Considerations." Human Vaccines & Immunotherapeutics, vol. 15, no. 5, 2019, pp. 1111-1122, https://doi.org/10.1080/21645515.2019.1571892.